CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 273-277

  Tzeng, C H ^a,b   Chen, P M ^a   Fan, S ^a   Liu, J H ^a   Chiou, T J ^a   Hsieh, R K ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Graft rejection; GVHD; Severe aplastic anemia

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; CYTOMEGALIC INCLUSION BODY DISEASE; DONOR; FAMILY; FEMALE; FUNGEMIA; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA SYSTEM; HUMAN; INTERSTITIAL PNEUMONIA; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PURE RED CELL ANEMIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CYCLOPHOSPHAMIDE; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0029788639     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Camitta BM, Thomas ED, Nathan DG et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504-514.
2. Storb R, Thomas ED, Buckner CD et al. Marrow transplantation for aplastic anemia. Semin Hematol 1984; 21: 27-35.
3. Bacigalupo A, DiGiorgio F, Congiu M et al. Treatment of severe aplastic anemia in Europe 1970-1983: a report of the EBMT SAA Working Party. Exp Hematol 1985; 13 (Suppl 17): 56-57.
4. Tzeng CH, Hsieh RK, Fan S et al. Bone marrow transplantation for severe aplastic anemia - a study of 21 Chinese patients in Taiwan. Transplantation 1992; 53: 569-574.
5. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants with aplastic anemia. Blood 1994; 84: 941-949.
6. Beatty PG, DiBartilomeo P, Storb R et al. Treatment of aplastic anemia with marrow grafts from related donors other than HLA genotypically-matched siblings. Clin Transplant 1987; 1: 117-122.
7. Hows JM, Kaminski E, Bradley BA et al. Unrelated and mismatched transplants in aplastic anemia. J Cell Biochem 1988; 12 (Suppl): 70 (Abstr.).
8. Filipovich AH, Ramsay NKC, McGlave P et al. Mismatched bone marrow transplantation at the University of Minnesota: use of related donors other than HLA-identical siblings and T cell depletion. In: Gale RP (ed). Recent Advances in Bone Marrow Transplantation. Liss: New York, 1983, pp 769-784.
9. Camitta B, Ash R, Menitove K et al. Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood 1989; 74: 1852-1857.
10. Storch S, Gale RP, Champlin R et al. Partially matched marrow transplantation for acute leukemia and aplastic anemia. In: Gale RP (ed). Recent Advances in Bone Marrow Transplantation. Liss: New York, 1983, pp 785-804.
11. Kernan N, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by The National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
12. Storb R, Deeg HJ, Farewell V et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119-125.
13. Camitta BM, Thomas ED, Nathan DG et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63-70.
14. NIH lymphocyte microcytotoxicity technique. In: NIAID Manual of Tissue Typing Techniques. DHEW Publication No. (NIH)80-545. Atlanta, GA: US Department of Health, Education and Welfare, 1979, p 313.
15. Van Rood JJ, Van Leeuwen A, Ploem JS. Simultaneous detection of two cell populations by two-color fluorescence and application to the recognition of B cell determinants. Nature 1976; 262: 795-797.
16. Tzeng CH, Chen PM, Chiu CF et al. HLA-mismatched allogeneic bone marrow transplantation. Chin Med J (Taipei) 1987; 39: 187-196.
17. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843.
18. Feig SA, Champlin R, Arenson E et al. Improved survival following bone marrow transplantation for aplastic anemia. Br J Haematol 1983; 54: 509-517.
19. Storb R, Thomas ED, Weiden PL et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report of 49 new cases from Seattle. Blood 1976; 48: 817-847.
20. Bortin MM, Gale RP, Rimm AA. Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. JAMA 1981; 245: 1132-1139.
21. Camitta BM, Storb R, Thomas ED. Aplastic anemia: pathogenesis, diagnosis, treatment and prognosis. New Engl J Med 1982; 306: 645-652.
22. Bozdech MJ, Sondel PM, Trigg ME et al. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol 1995; 13: 1201-1210.
23. Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA-matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 1986; 63: 221-230.
24. Martin PJ, Hansen JA, Buckner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664-672.
25. Ash RC, Horowitz MM, Gale RP et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-cell depletion. Bone Marrow Transplant 1991; 7: 443-452.
26. Tzeng CH, Chen PM, Chuang MW et al. Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy. Chin Med J (Taipei) 1989; 43: 21-28.
27. Ballou SP, Kushner I. Laboratory evaluation of inflammation. In: Kelley WN, Harris EDJ, Rruddy S, Sledge CB (eds). Textbook of Rheumatology. WB Saunders: Philadelphia, 1993, pp 671-679.
28. Winston DJ, Ho WG, Champlin RE. Cytomegalovirus infections after allogeneic bone marrow transplantation. Rev Infect Dis 1990; 12 (Suppl 7): S776-S792.
29. Gmur JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290-295.
30. Roychowdhury DF, Linker CA. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995; 16: 471-472.